Cornelia Liedtke
- Cancer Research top 0.1%
- Breast Cancer Treatment Studies 66
- Cancer Genomics and Diagnostics 16
- Oncology top 0.5%
- HER2/EGFR in Cancer Research 31
- Cancer Treatment and Pharmacology 29
- Cancer Cells and Metastasis 11
- Cancer-related Molecular Pathways 8
- Pathology and Forensic Medicine top 0.5%
- Breast Lesions and Carcinomas 15
-
- Advanced Breast Cancer Therapies 32
- Molecular Biology top 2%
- Co-authors
- Gabriel N. HortobágyiLajos PusztaiAna M. González-AnguloGϋnter von MinckwitzW. Fraser SymmansAttila TordaiFabrice AndréMassimo Cristofanilli
- Journals
- Journal of Clinical Oncology (23 papers)Breast Care (21 papers)Breast Cancer Research and Treatment (7 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Cornelia Liedtke
91 papers receiving 7.5k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Cancer Research 4.4k
- Oncology 4.3k
- Pathology and Forensic Medicine 1.7k
- Pulmonary and Respiratory Medicine 1.3k
- Molecular Biology 2.6k
Countries citing papers authored by Cornelia Liedtke
This map shows the geographic impact of Cornelia Liedtke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cornelia Liedtke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cornelia Liedtke more than expected).
Fields of papers citing papers by Cornelia Liedtke
This network shows the impact of papers produced by Cornelia Liedtke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cornelia Liedtke. The network helps show where Cornelia Liedtke may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cornelia Liedtke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 62 | |
| 2 | 2021 | 10 | |
| 3 | 2017 | 1 | |
| 4 | Subtypes of Triple-negative Breast Cancer Cell Lines React Differently to Eribulin Mesylate. | 2016 | 9 |
| 5 | 2016 | 37 | |
| 6 | 2016 | 121 | |
| 7 | 2016 | 12 | |
| 8 | 2016 | 49 | |
| 9 | 2015 | 2 | |
| 10 | 2014 | 48 | |
| 11 | 2014 | 18 | |
| 12 | 2013 | 4 | |
| 13 | Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort studybreakdown → | 2013 | 928 |
| 14 | 2011 | 39 | |
| 15 | 2010 | 27 | |
| 16 | 2010 | 41 | |
| 17 | 2009 | 248 | |
| 18 | 2009 | 336 | |
| 19 | In vitro chemosensitivity testing in invasive breast cancer: Increased sensitivity of the basal subtype is not independent of the tumor proliferation rate | 2006 | 1 |
| 20 | 2004 | 65 |
About Cornelia Liedtke
Cornelia Liedtke is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Molecular Biology, having authored 95 papers that have together received 7.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (66 papers), Advanced Breast Cancer Therapies (32 papers), HER2/EGFR in Cancer Research (31 papers), Cancer Treatment and Pharmacology (29 papers), Cancer Genomics and Diagnostics (16 papers), Breast Lesions and Carcinomas (15 papers), Cancer Cells and Metastasis (11 papers) and Cancer-related Molecular Pathways (8 papers). The work is most often cited by research in Cancer Research (4.4k citations), Oncology (4.3k citations), Pathology and Forensic Medicine (1.7k citations), Pulmonary and Respiratory Medicine (1.3k citations) and Molecular Biology (2.6k citations). Cornelia Liedtke has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Gabriel N. Hortobágyi, Lajos Pusztai, Ana M. González-Angulo, Gϋnter von Minckwitz, W. Fraser Symmans, Attila Tordai, Fabrice André, Massimo Cristofanilli, Carsten Denkert and Andrew Tutt. Their work appears in journals such as Journal of Clinical Oncology, Breast Care, Breast Cancer Research and Treatment, Breast Cancer Research and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.